Klaria Pharma Holding AB
6FN
Company Profile
Business description
Klaria Pharma Holding AB is a Swedish pharmaceutical company that develops rapid-acting products. By combining patented technology of a film that attaches to the oral mucosa and pharmaceuticals, the company has developed a drug distribution concept with many benefits and potential uses. Its patented drug delivery platform consists of an alginate-based polymer film that enables the absorption of a product’s active substance through the oral mucosa.
Contact
Virdings Alle 2
Uppsala754 50
CHET: +41 84464299
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2025
Employees
4
Stocks News & Analysis
stocks
Chart of the Week: The market may be underestimating Amcor’s long term potential
Our latest stock pitch.
stocks
Competitive pressures highlight need to lower costs for big 4 bank
Market reacts positively to results.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,034.50 | 50.40 | -0.55% |
| CAC 40 | 8,232.49 | 8.75 | -0.11% |
| DAX 40 | 24,041.62 | 339.84 | -1.39% |
| Dow JONES (US) | 47,425.39 | 829.43 | -1.72% |
| FTSE 100 | 9,807.68 | 103.74 | -1.05% |
| HKSE | 27,073.03 | 150.30 | 0.56% |
| NASDAQ | 22,839.03 | 567.43 | -2.42% |
| Nikkei 225 | 51,281.83 | 218.52 | 0.43% |
| NZX 50 Index | 13,597.87 | 73.86 | -0.54% |
| S&P 500 | 6,730.10 | 120.82 | -1.76% |
| S&P/ASX 200 | 8,753.40 | 46.00 | -0.52% |
| SSE Composite Index | 4,029.50 | 29.36 | 0.73% |